Current treatment approaches in extranodal MZL & the need to enhance prognostication strategies
Juan Alderuccio, MD, Sylvester Comprehensive Cancer Center, Miami, FL, discusses current approaches to prognostication and treatment in extranodal marginal zone lymphoma (EMZL). Dr Alderuccio explains that patients are assessed using the GELF criteria used for follicular lymphoma (FL), due to a lack of specific biomarkers to determine front-line treatment in MZL. To conclude, Dr Alderuccio describes treatments that could be provided depending on whether a patient meets these criteria, and highlights a recent study exploring the efficacy of bendamustine-rituximab in this patient population. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Watch video Current treatment approaches in extranodal MZL & the need to enhance prognostication strategies online without registration, duration hours minute second in high quality. This video was added by user VJHemOnc – Video Journal of Hematology & HemOnc 10 July 2023, don't forget to share it with your friends and acquaintances, it has been viewed on our site 346 once and liked it 2 people.